Cargando…
Improving Dissolution and Cytotoxicity by Forming Multidrug Crystals
Both rosiglitazone and metformin have effects on blood glucose regulation and the proliferation of liver cancer cells. Combination therapy with these two drugs is common and effective for the treatment of diabetes in the clinic, however, the application of these two drugs is influenced by the poor d...
Autores principales: | Bian, Xufei, Jiang, Lan, Zhou, Jing, Guan, Xiaoshu, Wang, Jingyu, Xiang, Peng, Pan, Junyi, Hu, Xiangnan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144552/ https://www.ncbi.nlm.nih.gov/pubmed/32188020 http://dx.doi.org/10.3390/molecules25061343 |
Ejemplares similares
-
A Glimepiride-Metformin Multidrug Crystal: Synthesis, Crystal Structure Analysis, and Physicochemical Properties
por: Bian, Xufei, et al.
Publicado: (2019) -
A New Co-Crystal of Synthetic Drug Rosiglitazone with Natural Medicine Berberine: Preparation, Crystal Structures, and Dissolution
por: Guan, Xiaoshu, et al.
Publicado: (2020) -
Multicomponent Crystal of Metformin and Barbital: Design, Crystal Structure Analysis and Characterization
por: Cai, Linhong, et al.
Publicado: (2021) -
Co-Crystals of Resveratrol and Polydatin with L-Proline: Crystal Structures, Dissolution Properties, and In Vitro Cytotoxicities
por: Lou, Yijie, et al.
Publicado: (2021) -
Crystal dissolution by particle detachment
por: Zhu, Guomin, et al.
Publicado: (2023)